Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Oxytocin on Attention Control
NCT04493515Unknown
- Sponsor
- University of Electronic Science and Technology of China
- Start
- Jul 2020
- Primary completion
- Dec 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxytocin in Autism Spectrum Disorder (ASD), sponsored by University of Electronic Science and Technology of China. Primary endpoints: Saccade/antisaccade latencies towards social (facial) versus non-social (shape) stimuli and Saccade/antisaccade error rates for social (facial) versus non-social (shape) stimuli. Status: unknown.
02
Drugs
oxytocin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT04493515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04493515.